Strength
50 mg/1
Manufacturer
Allergan, Inc.NDC
00023649810
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
1/2/2026
Active Ingredients
UBROGEPANTApproval Type
New Drug (NDA)
FDA Application
NDA211765On Market Since
12/23/2019
Pharmacological Classes
Calcitonin Gene-related Peptide Receptor Antagonist
Calcitonin Gene-related Peptide Receptor Antagonists
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
QULIPTA 10 MG TABLET
Brand
00074709530•AbbVie Inc.
$38.3668
per EA
QULIPTA 30 MG TABLET
Brand
00074709630•AbbVie Inc.
$38.4048
per EA
QULIPTA 60 MG TABLET
Brand
00074709430•AbbVie Inc.
$38.4749
per EA
NURTEC ODT 75 MG TABLET
Brand
72618300002•Pfizer Inc.
$128.7461
per EA
ZAVZPRET 10 MG NASAL SPRAY
Brand
00069350002•Pfizer Inc.
$190.1660
per EA